Solitron Devices INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink
Solitron Devices announces a significant 101% increase in net sales for its fiscal 2027 first quarter, driven by a strong backlog and a return to profitability.
OTC.Pink
Solitron Devices, Inc. announced the results of its Annual Meeting of Stockholders held on April 24, 2026, including the election of a Class III director and ratification of independent auditors.
OTC.Pink
Solitron Devices announced preliminary unaudited fiscal 2026 fourth quarter results, showing significant net sales growth but a decrease in net bookings.
OTC.Pink
Solitron Devices, Inc. announced its annual meeting date and that its Board of Directors will explore potential merger or sale opportunities, citing strong demand for defense-related companies.
OTC.Pink
Solitron Devices, Inc. announced significant increases in net sales, bookings, and backlog for its fiscal 2026 third quarter.
OTC.Pink
Solitron Devices, Inc. announced record-breaking fiscal 2026 third-quarter bookings to date of $13.8 million, significantly exceeding previous year's figures.
OTC.Pink
Solitron Devices, Inc. announced fiscal 2026 second quarter results, reporting a net loss despite significant increases in net sales, bookings, and backlog.
OTC.Pink
Solitron Devices, Inc. has updated its employment agreement with President and Chief Operating Officer Mark Matson, detailing new compensation, benefits, and restrictive covenants.
OTC.Pink
Solitron Devices, Inc. announced a 32% decrease in net sales and a net loss of $0.34 million for its fiscal 2026 first quarter, despite a 94% increase in backlog to a record $18.26 million.
OTC.Pink
Solitron Devices, Inc. announced its fiscal 2025 fourth quarter and full-year results, revealing a significant increase in bookings and backlog, particularly from major defense programs, despite a net loss in the fourth quarter and a decrease in full-year net income compared to a prior year boosted by non-recurring gains.
OTC.Pink
Solitron Devices experienced a surge in bookings for fiscal year 2025, driven by the acquisition of Micro Engineering, Inc. (MEI), but faced revenue declines in the fourth quarter due to lower backlog and increased rework.
OTC.Pink
Solitron Devices held its annual meeting on January 24, 2025, where shareholders elected two Class II directors, ratified the appointment of Whitley Penn LLP as auditor, and approved an advisory vote on executive compensation.
OTC.Pink
Solitron Devices experienced a 19% decrease in net sales but a 66% increase in net bookings for the third quarter of fiscal year 2025, alongside improved net income.
OTC.Pink
Solitron Devices reported a significant increase in bookings for the third quarter of fiscal year 2025, but experienced a decline in revenue compared to the same period last year.
OTC.Pink
Solitron Devices saw a 39% increase in net sales but a significant decrease in net income for the second quarter of fiscal year 2025, impacted by supplier issues and increased costs.
OTC.Pink
Solitron Devices announced a 95% increase in net sales and a significant improvement in net income for the first quarter of fiscal year 2025, driven by the acquisition of Micro Engineering Inc.
OTC.Pink
Solitron Devices announced a significant increase in net sales and net income for fiscal year 2024, boosted by the acquisition of Micro Engineering Inc. and increased demand.
OTC.Pink
Micro Engineering, a subsidiary of Solitron Devices, has obtained a $1.4 million loan from Bank of America to purchase the property it currently occupies.
OTC.Pink
Solitron Devices has announced increases to the base salaries of its CEO, CFO, President, COO, and the annual cash compensation for its Board of Directors, effective March 1, 2024.
OTC.Pink
Solitron Devices held its annual meeting on January 25, 2024, where stockholders elected two Class I directors, ratified the appointment of Whitley Penn LLP as the company's auditor, and approved an advisory vote on executive compensation.
OTC.Pink
Solitron Devices, Inc. announced a significant increase in net sales and net income for the third quarter of fiscal year 2024, largely due to the acquisition of Micro Engineering Inc. and increased demand.